Publication

Positive Practice Changes After the COVID-19 Pandemic: From the Advanced Practice Provider Perspective.

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    R Donald Harvey, Emory UniversityAaron Begue, Memorial Sloan Kettering Cancer CenterCaleb Raine, Emory UniversityRobin Yabroff, American Cancer Society
Language
  • English
Date
  • 2022-04
Publisher
  • Harborside
Publication Version
Copyright Statement
  • © 2022 Harborside™
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 13
Issue
  • 3
Start Page
  • 198
End Page
  • 201
Abstract
  • At the opening session of JADPRO Live Virtual 2021, panelists shared creative responses to the COVID-19 pandemic and considered strategies to effectively respond to crises that may impact cancer patients and practices in the future.
Author Notes
  • Dr. Harvey has served as a consultant to Amgen and GlaxoSmithKline and has received institutional research funding from Abbisko Therapeutics, AbbVie, Actuate, Alkermes, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Boston Biomedical, Calithera, FujiFilm, Genmab, GlaxoSmithKline, Infinity, InhibRx, Janssen, Lycera, Merck, Mersana, Meryx, Nektar, Pfizer, Puma Biotechnology, Rapt Therapeutics, Regeneron, Rgenix, Sanofi, Seattle Genetics, Sutro, Takeda, and Xencor. Mr. Begue and Mr. Raine have no conflicts of interest to disclose. Dr. Yabroff has served on the health equity advisory board of Flatiron Health.
Research Categories
  • Biology, Virology
  • Health Sciences, Health Care Management
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items

Thumbnail Title File Description Date Uploaded Visibility Actions
file details Publication File - vsn67.pdf Primary Content 2025-05-07 Public Download